Litcius/Paper detail

First week of social lockdown versus medical care against COVID-19 - with special reference to India

Kabita Das, Biswaranjan Paital

2020Current Trends in Biotechnology and Pharmacy28 citationsDOI

Abstract

The disease caused by Coronavirus (CoV) is called as Coronavirus Disease (COVID-19). It became pandemic in 210 countries and rolling data indicate that 2,606,635individuals are infected with the deadly pandemic disease and 713,812 have recovered, while, 182,114 have lost their lives. Although, few drugs namely Chloroquine, Hydr oxychl or oqui ne and Azi t hr omyci n, Tocilizumab, Lopinavir; Ritonavir and Tocilizumab are recommended on contextual basis for the treatment of COVID-19, the world is still waiting to come up with a specific vaccine or medicine to combat the disease. Without a specific medicine, countries such as Italy, USA, Spain and France, withthe most advanced health care systems are unsuccessful to control both the infection and death rate under COVID-19 infection. India being the world’s 2 ndlargest populous country, where, the health care system is under developed, with major portion of people live less-hygienic life, has contracted the disease at a slower rate as compared to the above countries. India has achieved this through employing social distancing by following a strict lockdown. This article is focused on social distancing of India and the kind of social interaction that can be adapted by people during lockdown.

Topics & Concepts

Social distancePandemicTocilizumabMedicineDiseaseLopinavirCoronavirus disease 2019 (COVID-19)Health careMortality rateEnvironmental healthEconomic growthInfectious disease (medical specialty)Internal medicineEconomicsCOVID-19 epidemiological studies
First week of social lockdown versus medical care against COVID-19 - with special reference to India | Litcius